Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin‑17 receptor E is a member of the interleukin‑17 receptor family, which consists of several structurally related transmembrane proteins involved in immune signaling. IL‑17RE acts as a specific functional receptor for the cytokine interleukin‑17C. Upon ligand binding, it signals through intracellular pathways such as NF-kappa-B and MAPK, requiring the adaptor protein TRAF3IP2/ACT1 for downstream signaling[4]. This pathway plays an important role in mucosal barrier immunity and host defense against pathogens at epithelial surfaces[2]. IL‑17RE is highly expressed in Th17 cells and contributes to immune responses by mediating pro-inflammatory signals that help maintain tissue integrity during infection or inflammation[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin-17 receptor E (IL-17RE).